Lyra Therapeutics, Inc. (the Company or Lyra) announced the appointment of John Bishop, Ph.D., as Chief Technology Officer, effective February 27, 2023. Dr. Bishop will lead the commercial scale-up of Lyra's manufacturing operations for the Company's late-stage product candidates, LYR-210 and LYR-220.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3204 USD | +0.12% | -2.32% | -93.89% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-93.89% | 19.53M | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- LYRA Stock
- News Lyra Therapeutics, Inc.
- Lyra Therapeutics, Inc. Announces Appointment of John Bishop as Chief Technology Officer